Metabolic syndrome: Does it differ between women and men?

Cardiovascular Drugs and Therapy

Volumn 29, Issue 4, 2015, Pages 329-338

  Rochlani, Yogita ^a   Pothineni, Naga Venkata ^a   Mehta, Jawahar L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cardiovascular disease; Dyslipidemia; Gender differences; Hypertension; Insulin resistance; Metabolic syndrome; Obesity; Pathophysiology of metabolic syndrome; Role of hormones in metabolic syndrome; Sex differences

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; ESTROGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROGESTERONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; HORMONE;

AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CORONARY ARTERY ATHEROSCLEROSIS; DIET RESTRICTION; DIETARY INTAKE; DYSLIPIDEMIA; EDUCATIONAL STATUS; EPIDEMIC; EPIDEMIOLOGICAL DATA; ESTROGEN THERAPY; FEMALE; FOOD INTAKE; GEOGRAPHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INCOME; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; MALE; MENSTRUAL CYCLE; METABOLIC SYNDROME X; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RACE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK REDUCTION; SEX DIFFERENCE; WAIST CIRCUMFERENCE; ANIMAL; METABOLISM; POLYCYSTIC OVARY SYNDROME; SEXUAL DEVELOPMENT;

ANIMALS; FEMALE; HORMONES; HUMANS; MALE; METABOLIC SYNDROME X; POLYCYSTIC OVARY SYNDROME; SEX CHARACTERISTICS;

EID: 84943349808     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/s10557-015-6593-6     Document Type: Article

References (87)

1. Grundy SM, Hansen B, Smith Jr SC, Cleeman JI, Kahn RA, American Heart Association, National Heart, Lung, and Blood Institute, American Diabetes Association. Clinical management of metabolic syndrome: report of the American heart association/national heart, lung, and blood institute/American diabetes association conference on scientific issues related to management. Arterioscler Thromb Vasc Biol. 2004; 24(2): e19-24.
2. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008; 28(4): 629-36.
3. Wenger NK. Women and coronary heart disease: a century after herrick: understudied, underdiagnosed, and undertreated. Circulation. 2012; 126(5): 604-11.
4. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988; 37(12): 1595-607.
5. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991; 14(3): 173-94.
6. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, et al. Hypertriglyceridemic waist: a marker of the atherogenicmetabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000; 102(2): 179-84.
7. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med. 1989; 149(7): 1514-20.
8. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001; 24(4): 683-9.
9. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15(7): 539-53.
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001; 285(19): 2486-97.
11. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006; 23(5): 469-80.
12. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation. 2005; 112(17): 2735-52.
13. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, Lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; and International association for the study of obesity. Circulation. 2009; 120(16): 1640-5.
14. Lin CC, Liu CS, Li CI, Lin WY, Lai MM, Lin T, et al. The relation of metabolic syndrome according to five definitions to cardiovascular risk factors-a population-based study. BMC Public Health. 2009; 9: 484.
15. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United states, 2003-2006. Natl Health Stat Rep. 2009; 13: 1-7.
16. Meigs JB, Wilson PW, Nathan DM, D'Agostino RBS, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio heart and Framingham offspring studies. Diabetes. 2003; 52(8): 2160-7.
17. Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U. S. adults: NHANES III to NHAN ES 1999-2006. Diabetes Care. 2011; 34(1): 216-9.
18. Miller JM, Kaylor MB, Johannsson M, Bay C, Churilla JR. Prevalence of metabolic syndrome and individual criterion in US adolescents: 2001-2010 national health and nutrition examination survey. Metab Syndr Relat Disord. 2014; 12(10): 527-32.
19. Loucks EB, Rehkopf DH, ThurstonRC, Kawachi I. Socioeconomic disparities in metabolic syndrome differ by gender: evidence from NHANES III. Ann Epidemiol. 2007; 17(1): 19-26.
20. Cherry CO, Serieux E, Didier M, Nuttal ME, Schuster RJ. Prevalence of risk factors for the metabolic syndrome in the middle income Caribbean nation of St. Lucia. Adv Prev Med. 2014; 2014: 501972.
21. Ishii S, Tanaka T, Akishita M, Ouchi Y, Tuji T, Iijima K, et al. Metabolic syndrome, Sarcopenia and role of sex and age: crosssectional analysis of Kashiwa cohort study. PLoS One. 2014; 9(11), e112718.
22. Sobko T, Trindade D, Lao QX, WongM, Io TK, Wa CK, et al. Men in Macau SAR have higher prevalence in metabolic syndrome and among related metabolic components: a cross-sectional Macau health survey. BMC Public Health. 2014; 14: 1065.
23. Yu S, Guo X, Yang H, Zheng L, SunY. An update on the prevalence of metabolic syndrome and its associated factors in rural northeast China. BMC Public Health. 2014; 14: 877, 2458-14-877.
24. Xi B, He D, Hu Y, Zhou D. Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: the china health and nutrition survey in 2009. Prev Med. 2013; 57(6): 867-71.
25. Mabry RM, Reeves MM, Eakin EG, Owen N. Gender differences in prevalence of the metabolic syndrome in gulf cooperation council countries: a systematic review. Diabet Med. 2010; 27(5): 593-7.
26. Erem C, Hacihasanoglu A, Deger O, Topbas M, Hosver I, Ersoz HO, et al. Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study. Endocrine. 2008; 33(1): 9-20.
27. Athyros VG, Bouloukos VI, Pehlivanidis AN, Papageorgiou AA, Dionysopoulou SG, Symeonidis AN, et al. The prevalence of the metabolic syndrome in Greece: the MetS-Greece multicentre study. Diabetes Obes Metab. 2005; 7(4): 397-405.
28. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, et al. Frequency of theWHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002; 28(5): 364-76.
29. Dallongeville J, Cottel D, Arveiler D, Tauber JP, Bingham A, Wagner A, et al. The association of metabolic disorders with the metabolic syndrome is different in men and women. Ann Nutr Metab. 2004; 48(1): 43-50.
30. Levine DA, Lewis CE, Williams OD, SaffordMM, Liu K, Calhoun DA, et al. Geographic and demographic variability in 20-year hypertension incidence: the CARDIA study. Hypertension. 2011; 57(1): 39-47.
31. Ong KL, Tso AW, Lam KS, Cheung BM. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension. 2008; 51(4): 1142-8.
32. Denton KM, Hilliard LM, Tare M. Sex-related differences in hypertension: seek and ye shall find. Hypertension. 2013; 62(4): 674-7.
33. Rossi P, Frances Y, Kingwell BA, Ahimastos AA. Gender differences in artery wall biomechanical properties throughout life. J Hypertens. 2011; 29(6): 1023-33.
34. Hilliard LM, Mirabito KM, Denton KM. Unmasking the potential of the angiotensin AT2 receptor as a therapeutic target in hypertension in men and women: what we know and what we still need to find out. Clin Exp Pharmacol Physiol. 2013; 40(8): 542-50.
35. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Comparison of diabetes diagnostic categories in the U. S. population according to the 1997 american diabetes association and 1980-1985 world health organization diagnostic criteria. Diabetes Care. 1997; 20(12): 1859-62.
36. Glucose tolerance and mortality: comparison of WHO and American diabetes association diagnostic criteria. The DECODE study group. European diabetes epidemiology group. Diabetes epidemiology: Collaborative analysis of diagnostic criteria in Europe. Lancet. 1999; 354(9179): 617-21.
37. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting Glycaemia: the current status on definition and intervention. Diabet Med. 2002; 19(9): 708-23.
38. Varlamov O, Bethea CL, Roberts Jr CT. Sex-specific differences in lipid and glucose metabolism. Front Endocrinol (Lausanne). 2015; 5: 241.
39. Aldhoon-Hainerova I, Zamrazilova H, Dusatkova L, Sedlackova B, Hlavaty P, Hill M, et al. Glucose homeostasis and insulin resistance: prevalence, gender differences and predictors in adolescents. Diabetol Metab Syndr. 2014; 6(1): 100. eCollection 2014.
40. Barrett-Connor E, Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women andmen. The Rancho Bernardo study. Diabetes Care. 1998; 21(8): 1236-9.
41. Goff Jr DC, Bertoni AG, Kramer H, Bonds D, Blumenthal RS, Tsai MY, et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation. 2006; 113(5): 647-56.
42. Johnson JL, Slentz CA, Duscha BD, Samsa GP, McCartney JS, Houmard JA, et al. Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study. Atherosclerosis. 2004; 176(2): 371-7.
43. Bittner V. Perspectives on dyslipidemia and coronary heart disease in women. J Am Coll Cardiol. 2005; 46(9): 1628-35.
44. NgM, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014; 384(9945): 766-81.
45. Beydoun MA, Wang Y. Gender-ethnic disparity in BMI and waist circumference distribution shifts in US adults. Obesity (Silver Spring). 2009; 17(1): 169-76.
46. Garawi F, Devries K, Thorogood N, Uauy R. Global differences between women and men in the prevalence of obesity: is there an association with gender inequality? Eur J Clin Nutr. 2014; 68(10): 1101-6.
47. Kahn HS, Bullard KM, Barker LE, Imperatore G. Differences between adiposity indicators for predicting all-cause mortality in a representative sample of United States non-elderly adults. PLoS One. 2012; 7(11), e50428.
48. Pradhan AD. Sex differences in the metabolic syndrome: implications for cardiovascular health in women. Clin Chem. 2014; 60(1): 44-52.
49. Meyer MR, Clegg DJ, Prossnitz ER, Barton M. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxf). 2011; 203(1): 259-69.
50. Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH, van der Schouw YT. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. Int J Epidemiol. 2011; 40(1): 189-207.
51. Bhasin S, Jasjua GK, Pencina M, D'Agostino RS, Coviello AD, Vasan RS, et al. Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the Framingham heart study. Diabetes Care. 2011; 34(11): 2464-70.
52. Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: the study of women's health across the nation. Arch Intern Med. 2008; 168(14): 1568-75.
53. Kupelian V, Hayes FJ, Link CL, Rosen R, McKinlay JB. Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups. J Clin Endocrinol Metab. 2008; 93(9): 3403-10.
54. Duskova M, Pospisilova H. The role of non-aromatizable testosterone metabolite in metabolic pathways. Physiol Res. 2011; 60(2): 253-61.
55. Bjorntorp P. The origins and consequences of obesity. Diab Ciba Found Sym. 1996; 201: 68-80. discussion 80-9, 188-93.
56. Kalyani RR, Franco M, Dobs AS, Ouyang P, Vaidya D, Bertoni A, et al. The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab. 2009; 94(11): 4127-35.
57. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care. 2004; 27(5): 1036-41.
58. Li C, Ford ES, Li B, Giles WH, Liu S. Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care. 2010; 33(7): 1618-24.
59. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006; 295(11): 1288-99.
60. Vikan T, Schirmer H, Njolstad I, Svartberg J. Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. Eur J Endocrinol. 2010; 162(4): 747-54.
61. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM, Liu S. Sex Hormone-Binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009; 2015/02; 361(12): 1152-63.
62. Haring R, Volzke H, Spielhagen C, Nauck M, Wallaschofski H. The role of sex hormone-binding globulin and testosterone in the risk of incident metabolic syndrome. Eur J Prev Cardiol. 2013; 20(6): 1061-8.
63. Daka B, Rosen T, Jansson PA, Larsson CA, Rastam L, Lindblad U. Low sex hormone-binding globulin is associated with hypertension: a cross-sectional study in a Swedish population. BMC Cardiovasc Disord. 2013; 13: 30.
64. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, StefanickML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA. 2002; 288(3): 321-33.
65. Velez LM, Motta AB. Association between polycystic ovary syndrome and metabolic syndrome. Curr Med Chem. 2014; 21(35): 3999-4012.
66. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of themetabolic syndrome inwomen with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005; 90(4): 1929-35.
67. Hillman JK, Johnson LN, Limaye M, Feldman RA, Sammel M, Dokras A. Black women with Polycystic Ovary Syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women with PCOS [corrected]. Fertil Steril. 2014; 101(2): 530-5.
68. Essah PA, Nestler JE. The metabolic syndrome in polycystic ovary syndrome. J Endocrinol Investig. 2006; 29(3): 270-80.
69. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 56(14): 1113-32.
70. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005; 28(7): 1769-78.
71. Kuk JL, Ardern CI. Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk. Diabetes Care. 2010; 33(11): 2457-61.
72. Guize L, Thomas F, Pannier B, Bean K, Jego B, Benetos A. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions. Diabetes Care. 2007; 30(9): 2381-7.
73. Hari P, Nerusu K, Veeranna V, Sudhakar R, Zalawadiya S, Ramesh K, et al. A gender-stratified comparative analysis of various definitions of metabolic syndrome and cardiovascular risk in a multiethnic U. S. population. Metab Syndr Relat Disord. 2012; 10(1): 47-55.
74. Beltrán-Sánchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and trends of metabolic syndrome in the adult U. S. population, 1999-2010. J Am Coll Cardiol. 2013; 62(8): 697-703.
75. Riediger ND, Clara I. Prevalence of metabolic syndrome in the Canadian adult population. CMAJ. 2011; 183(15): E1127-34.
76. Heiss G, SnyderML, Teng Y, Schneiderman N, LlabreMM, Cowie C, et al. Prevalence of metabolic syndrome among Hispanics/Latinos of diverse background: the Hispanic community health study/study of Latinos. Diabetes Care. 2014; 37(8): 2391-9.
77. Scuteri A, Najjar SS, Morrell CH, Lakatta EG, Cardiovascular Health Study. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the cardiovascular health study. Diabetes Care. 2005; 28(4): 882-7.
78. Ford ES, Li C, Zhao G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes. 2010; 2(3): 180-93.
79. Yang JJ, Yoon HS, Lee SA, Choi JY, Song M, Han S, et al. Metabolic syndrome and sex-specific socio-economic disparities in childhood and adulthood: the Korea national health and nutrition examination surveys. Diabet Med. 2014; 31(11): 1399-409.
80. Podang J, Sritara P, Narksawat K. Prevalence and factors associated with metabolic syndrome among a group of Thai working population: a cross sectional study. J Med Assoc Thai. 2013; 96 Suppl 5: S33-41.
81. Deepa M, Farooq S, Datta M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai urban rural epidemiology study (CURES-34). Diabetes Metab Res Rev. 2007; 23(2): 127-34.
82. Deedwania PC, Gupta R, Sharma KK, Achari V, Gupta B, Maheshwari A, et al. High prevalence of metabolic syndrome among urban subjects in India: a multisite study. Diabetes Metab Syndr. 2014; 8(3): 156-61.
83. El Brini O, Akhouayri O, Gamal A, Mesfioui A, Benazzouz B. Prevalence of metabolic syndrome and its components based on a harmonious definition among adults in Morocco. Diabetes Metab Syndr Obes. 2014; 7: 341-6.
84. Malik M, Razig SA. The prevalence of the metabolic syndrome among the multiethnic population of the United Arab Emirates: a report of a national survey. Metab Syndr Relat Disord. 2008; 6(3): 177-86.
85. Al-Daghri NM, Alkharfy KM, Al-Attas OS, Khan N, Alfawaz HA, Alghanim SA, et al. Gender-dependent associations between socioeconomic status and metabolic syndrome: a cross-sectional study in the adult Saudi population. BMC Cardiovasc Disord. 2014; 14: 51.
86. Vernay M, Salanave B, de Peretti C, Druet C, Malon A, Deschamps V, et al. Metabolic syndrome and socioeconomic status in France: the French nutrition and health survey (ENNS, 2006-2007). Int J Public Health. 2013; 58(6): 855-64.
87. Maggi S, Noale M, Gallina P, Bianchi D, Marzari C, Limongi F, et al. Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: the Italian longitudinal study on aging. J Gerontol A Biol Sci Med Sci. 2006; 61(5): 505-10.